John Barnard

NNC Group LLC provides product promotion and product support solutions. It develops and provides technology based logistics & communications solutions to the pharmaceutical, financial services and consumer products industries. It has developed technology enabled processes and logistics systems that function in highly complex regulated environments where the need for thorough, disciplined processes, verifiable data and advanced communication & information technology support is critical. Its other services include recall planning, execution, customer notification, recall logistics and information dissemination. The company was founded in 1994 and is headquartered in Indianapolis, IN.

Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana.

Barnard Associates, Inc(Barnard Associates) is a venture capital firm founded by John H. Barnard in 1994. The firm is headquartered in Indiana, United States.

Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN.

Flowco, Inc. develops biomedical devices for diagnostics. Its impedance technology provides a platform for the development of products that aid in sizing, diagnosis and treatment of diseased vessels. The company was founded in 2007 by Ghassan Kassab and is headquartered in Indianapolis, IN.

YourEncore, Inc. provides business support services. It offers business solutions for the research, development, and commercialization needs of clients across the pharmaceutical, biotechnology, consumer care, food, and aerospace industries. The company was founded by Bradley W. Lawson, John H. Barnard and Timothy J. Tichenor in 2003 and is headquartered in Indianapolis, IN.

CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA.